Substituted quinazolinones for treating neurological conditions

Details Substituted quinazolinones for treating neurological conditions Substituted quinazolinones for treating neurological conditions

2005-04-01

2011-12-27

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S287000

Reexamination Certificate

active

08084459

ABSTRACT:
Compounds of the formulaor salts, tautomers or isomers thereof, are useful for treating neurological conditions, especially neurodegenerative disorders, such as Alzheimer's disease.

REFERENCES:
patent: 5756502 (1998-05-01), Padia
patent: 6337332 (2002-01-01), Carpino
patent: 2002/0161014 (2002-10-01), Sadhu et al.
patent: 2004/0048853 (2004-03-01), Bergnes
patent: 2005/0043239 (2005-02-01), Douangpanya et al.
patent: 2005/0282834 (2005-12-01), Malik et al.
patent: 713767 (1954-08-01), None
patent: WO 97/10221 (1997-03-01), None
patent: WO 98/21186 (1998-05-01), None
patent: WO 98/26664 (1998-06-01), None
patent: WO 00/24707 (2000-05-01), None
patent: WO 01/16114 (2001-03-01), None
patent: WO 01/30768 (2001-05-01), None
patent: WO 01/81346 (2001-11-01), None
patent: WO 01/98278 (2001-12-01), None
patent: WO 02/48115 (2002-06-01), None
patent: WO 03/039460 (2003-05-01), None
patent: WO 03/043961 (2003-05-01), None
patent: WO 03/043995 (2003-05-01), None
patent: WO 03/070701 (2003-08-01), None
patent: WO 03/076418 (2003-09-01), None
patent: WO 03/084544 (2003-10-01), None
patent: WO 2004/031161 (2004-04-01), None
patent: WO 2005/016348 (2005-02-01), None
patent: WO 2005/016349 (2005-02-01), None
patent: WO 2005/051922 (2005-06-01), None
patent: WO 2005/067901 (2005-07-01), None
patent: WO 2005/095360 (2005-10-01), None
patent: WO 2005/011789 (2005-12-01), None
patent: WO 2005/112935 (2005-12-01), None
patent: WO 2005/115993 (2005-12-01), None
patent: WO 2005/120511 (2005-12-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, p. 18.
Wolff, Manfred E., Ed. Burger's Medicinal Chemistry and Drug Discovery—Fifth Edition, New York: John Wiley & Sons, 1996, vol. 1, pp. 975-976.
Iyer, et al. J. Sci. Ind. Res., 20C, 1961, 175-177.
STN File CA, abstract No. 57:56272 & R.N. Iyer and M.L. Dhar, Journal of Scientific & Industrial Research (1961), 20C, 175-177.
R.N. Iyer et al., “Studies in Potential Amodbicides: Part VII-Synthesis of Some 3-Alkyl-2-styryl-8-hydroxy- (& 8-methoxy) - 4-quinazolones”, J. Sci. Industr. Res., 17C, (1958).

Affiliated with

Also associated with

Rating

Substituted quinazolinones for treating neurological conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted quinazolinones for treating neurological conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazolinones for treating neurological conditions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4314238